|
|||||
|
|
What’s new on therapies for elevated lipoprotein(a) |
|
| Authors: | Natalie C. Ward Carl J. Schultz |
| Affiliation: | 1. School of Public Health, Faculty of Health Sciences, Curtin University, Perth, Australia;2. School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia;3. School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia;4. Department of Cardiology, Royal Perth Hospital, Perth, Australia |
| Abstract: | |
| Keywords: | Lipoprotein (a) atherosclerotic cardiovascular disease lipids PCSK9 inhibitors antisense oligonucleotides |